% | $
Quotes you view appear here for quick access.

Agenus Inc. Message Board

  • dtrader12 dtrader12 Sep 17, 2013 9:47 AM Flag

    Will close red - from adam feuerstein:

    $AGEN Slick interweaving of historical survival data into this PR about a single-arm study. Highly misleading

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You are wrong to a $100M company with QS-21 at least worth that. Any potential start of a phase III is big news for a microstock like this.

      Historically GSK acquired Corixas for $300M plus $100M debt. Corixa's best asset at that time is the MPL vaccine adjuvant. QS-21 is equally important as MPL as it is used in 2/3 of future GSK's vaccine projects. Don't be surprised that GSK acquire this little biotech for around $300M.

8.06-0.12(-1.47%)Jun 1 4:00 PMEDT